S. 2780 upends the IP system. Mandating identical disclosure to FDA and PTO risks patents and trade secrets.

We must enter the fray against the live threats to the successful U.S. innovation model. If these threats take root, we have much at stake to lose.

Coalition urges Senate Judiciary Committee to pass two bipartisan patent bills to strengthen patents and promote American innovation.

Conservative leaders call on members of Congress to take bipartisan action to confront the growing threat from China when it comes to technology and research.

Restoring patent rights—namely through access to injunctive relief—would help reverse courts’ adverse effects and boost IP’s market value.

The hype from Harris has claimed that IRA drug price controls will save beneficiaries on prescription costs. However, most patients won’t see any cost savings from price setting.

CPR’s James Edwards talks IP’s importance on CFIF’s new podcast IP Protection Matters.

From land deeds to patents, societies that respect property rights and enable people to accumulate property and protect it from theft thrive.

The legal apparatus in place to protect innovators [is] paramount for protecting America's culture of innovation and its place at the forefront in creating new technologies. 

The Biden administration is rushing to finalize its proposal for the government to retroactively terminate patent licensing agreements. Instead, it ought to rush to scrap it.

A new study finds that two centuries of U.S. innovation leadership is faltering because of judges’ rulings that allow infringers to keep benefiting commercially from purloined inventions.

World IP Day makes for a great time to take stock of the economic benefits intellectual property fosters.

Global piracy affects the livelihoods of millions of people. It steals from those holding U.S. jobs in film and TV. Under the 1998 Digital Millennium Copyright Act, it’s costly and time-consuming to fight piracy.

Sen. Thom Tillis' S. 2140, the Patent Eligibility Restoration Act resolves confusion, retaining existing statutory categories for patent-eligible subject matter and replaces ambiguous judicially created exceptions.

The wildly successful, innovation-fostering Bayh-Dole contains no reference to prices of eventual products in connection with the law’s march-in provision or anything else.

Several lawmakers with experience and expertise in IP spotted reasons for concern with PAPA. PAPA was being fast-tracked, taking a leap away from the Founders’ democratized, merit-based patent system.

March-in introduces extensive uncertainty about patents remaining exclusive for product development and commercialization efforts using private investment dollars.

The Global Innovation Policy Center’s new IP principles espouse the importance of IP for America’s innovation, security and prosperity. 

A rash of cookie-cutter op-eds signed by former Congressmen popping up around the country aims to undermine American patent rights on behalf of Big Tech interests.

Two bipartisan bills would restore some patent reliability. Other legislation introduced or seeking a sponsor threatens to reduce patent reliability and America’s global leadership in innovation versus China. 

Quiet title is essential to property rights—whether land where the EPA asserts unconstitutionally broad “navigable waters” regulations or by unfair eminent domain.

The EC 's regulatory framework hampers standard-essential patents. The regulatory train wreck will harm U.S. and European innovators and help China's competitiveness.